Showing 2 results for Soleymani
Ali Asghar Soleymani, Alireza Rahimi, Eidi Alijani, Amir Sarshin,
Volume 21, Issue 6 (3-2022)
Abstract
Background: Cardiovascular disease is a major cause of death in patients with type 1 diabetes, and cardiovascular risk remains high even in patients with type 1 diabetes with good metabolic control. The aim of this study was to evaluate the effect of six weeks of aerobic exercise on inflammation and damage indicators of heart tissue in type 1 diabetic male rats.
Methods: In this experimental study, 19 male Wistar rats (mean weight 200-250 g) were randomly divided into four groups: aerobic training, sham, control and healthy. In this study, induction of type 1 diabetes was performed by injecting a single dose of streptozotocin dissolved in sodium citrate buffer intraperitoneally. Aerobic exercise program was performed with intensity of 50-60% VO2max, 5 days a week for 6 weeks. After anesthesia, an autopsy was performed and left ventricle of the heart was removed. Levels of Tumour necrosis factor α (TNF-α), Peroxisome proliferator-activated receptor-γ coactivator (PGC-1α) and Creatine kinase (CK) in rat heart tissue were measured by Western blotting. Data were analyzed by One-way ANOVA and Tukey post hoc test at the P<0.05.
Results: The results showed that six weeks of aerobic training led to significant decrease in TNF-α and CK and significant increase in PGC-1α of the heart tissue in type 1 diabetic rats (P<0.001).
Conclusion: According to the results, it seems that aerobic training can help improve the inflammation and damage indicators of heart in type 1 diabetes.
Yunus Soleymani, Javad Hatami, Moloud Payab, Ata Pourabbasi,
Volume 26, Issue 2 (7-2026)
Abstract
Background: Metabolic syndrome (MetS) is associated with a higher risk of cognitive dysfunction and brain structural alterations, yet the specific contributions of its components and underlying mechanisms remain unclear.
Methods: This narrative review integrates findings from neuroimaging, clinical, and molecular studies to provide a conceptual understanding of how MetS affects cognition. A non-systematic and targeted search was conducted up to June 2025 using terms such as metabolic syndrome, cognition, and magnetic resonance imaging (MRI). Studies were selected based on their relevance and conceptual contribution.
Results: Evidence converges on inflammation, oxidative stress, vascular injury, and insulin resistance as key mechanisms linking MetS to gray and white matter changes and cognitive impairment. Structural and functional MRI studies demonstrate disrupted brain connectivity and reduced hippocampal volume in individuals with MetS. Gender and genetic differences may also influence the strength of this association. The coexistence of metabolic syndrome and cognitive dysfunction is linked to reduced health-related quality of life.
Conclusion: The narrative synthesis highlights how metabolic and vascular factors jointly drive neurocognitive decline and underscores the need for longitudinal and mechanistic research.
